Acinetobacter infection in the ICU

被引:32
作者
Murray, Clinton K. [1 ]
Hospenthal, Duane R. [1 ]
机构
[1] Brooke Army Med Ctr, Infect Dis Serv, Ft Sam Houston, TX 78234 USA
关键词
D O I
10.1016/j.ccc.2007.12.005
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Acinetobacter is a formidable challenge to managing critically ill patients. This pathogen's ability to rapidly develop antimicrobial resistance to all currently available antimicrobial agents is concerning because increasing data support attributable mortality to these bacteria when associated with hospitalized patients with comorbidities and severe illness. The role of dual therapy is currently unclear and might be associated with increased toxicities without proven synergy or ability to prevent the development of resistance. Infection control and antibiotic control measures might have the greatest impact on these bacteria. Continued efforts are needed to develop new antimicrobial agents against this pathogen and assess the ideal currently available agents.
引用
收藏
页码:237 / +
页数:13
相关论文
共 84 条
  • [11] Identification of Acinetobacter species and genotyping of Acinetobacter baumannii by multilocus PCR and mass spectrometry
    Ecker, Joseph A.
    Massire, Christian
    Hall, Thomas A.
    Ranken, Raymond
    Pennella, Thuy-Trang D.
    Ivy, Cristina Agasino
    Blyn, Lawrence B.
    Hofstadler, Steven A.
    Endy, Timothy P.
    Scott, Paul T.
    Lindler, Luther
    Hamilton, Tacita
    Gaddy, Charla
    Snow, Kerry
    Pe, Marie
    Fishbain, Joel
    Craft, David
    Deye, Gregory
    Riddell, Scott
    Milstrey, Eric
    Petruccelli, Bruno
    Brisse, Sylvain
    Harpin, Vanessa
    Schink, Amy
    Ecker, David J.
    Sampath, Rangarajan
    Eshoo, Mark W.
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2006, 44 (08) : 2921 - 2932
  • [12] Investigation of an outbreak of multidrug-resistant Acinetobacter baumannii in trauma intensive care unit
    El Shafie, SS
    Alishaq, M
    Garcia, ML
    [J]. JOURNAL OF HOSPITAL INFECTION, 2004, 56 (02) : 101 - 105
  • [13] Risk factors for the isolation of multi-drug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa:: a systematic review of the literature
    Falagas, M. E.
    Kopterides, P.
    [J]. JOURNAL OF HOSPITAL INFECTION, 2006, 64 (01) : 7 - 15
  • [14] Falagas ME, 2006, CRIT CARE, V10, DOI [10.1186/cc4910, 10.1186/cc4869]
  • [15] Intraventricular or intrathecal use of polymyxins in patients with Gram-negative meningitis: a systematic review of the available evidence
    Falagas, Matthew E.
    Bliziotis, Ioannis A.
    Tam, Vincent H.
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 (01) : 9 - 25
  • [16] Comparison of mortality of patients with Acinetobacter baumannii bacteraemia receiving appropriate and inappropriate empirical therapy
    Falagas, Matthew E.
    Kasiakou, Sofia K.
    Rafailidis, Petros I.
    Zouglakis, George
    Morfou, Panayiota
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 57 (06) : 1251 - 1254
  • [17] Emergence of resistance in Pseudomonas aeruginosa and Acinetobacter species after the use of antimicrobials for burned patients
    Ferreira, ACB
    Gobara, S
    Costa, SF
    Sauaia, N
    Mamizuka, EM
    Van der Heijden, IM
    Soares, RE
    Almeida, GD
    Fontana, C
    Levin, AS
    [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2004, 25 (10) : 868 - 872
  • [18] Bacterial colonization of patients undergoing international air transport:: A prospective epidemiologic study
    Fischer, D
    Veldman, A
    Diefenbach, M
    Schäfer, V
    [J]. JOURNAL OF TRAVEL MEDICINE, 2004, 11 (01) : 44 - 48
  • [19] Comparative genomics of multidrug resistance in Acinetobacter baumannii
    Fournier, Pierre-Edouard
    Vallenet, David
    Barbe, Valerie
    Audic, Stephane
    Ogata, Hiroyuki
    Poirel, Laurent
    Richet, Herve
    Robert, Catherine
    Mangenot, Sophie
    Abergel, Chantal
    Nordmann, Patrice
    Weissenbach, Jean
    Raoult, Didier
    Claverie, Jean-Michel
    [J]. PLOS GENETICS, 2006, 2 (01): : 62 - 72
  • [20] Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001-2004)
    Gales, AC
    Jones, RN
    Sader, HS
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2006, 12 (04) : 315 - 321